Acadian Asset Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,320
| Closed | -$35K | – | 1719 |
|
|
2024
Q3 | $35K | Buy |
+3,320
| New | +$35K | ﹤0.01% | 1893 |
|
|
2021
Q2 | – | Sell |
-610
| Closed | -$5K | – | 2027 |
|
|
2021
Q1 | $5K | Buy |
+610
| New | +$5K | ﹤0.01% | 2020 |
|
|
2020
Q4 | – | Sell |
-80,759
| Closed | -$757K | – | 2218 |
|
|
2020
Q3 | $757K | Sell |
80,759
-6,203
| -7% | -$58.1K | ﹤0.01% | 1007 |
|
|
2020
Q2 | $161K | Buy |
86,962
+56,278
| +183% | +$104K | ﹤0.01% | 1563 |
|
|
2020
Q1 | $51K | Hold |
30,684
| – | – | ﹤0.01% | 1498 |
|
|
2019
Q4 | $88K | Buy |
30,684
+18,939
| +161% | +$54.3K | ﹤0.01% | 1502 |
|
|
2019
Q3 | $68K | Buy |
11,745
+3,595
| +44% | +$20.8K | ﹤0.01% | 1567 |
|
|
2019
Q2 | $85K | Buy |
8,150
+4,679
| +135% | +$48.8K | ﹤0.01% | 1397 |
|
|
2019
Q1 | $61K | Buy |
+3,471
| New | +$61K | ﹤0.01% | 1633 |
|